| Literature DB >> 24696845 |
Jennifer L Lansdowne1, Declan Devine1, Ursula Eberli1, Pieter Emans2, Tim J M Welting2, Jim C E Odekerken2, Damiano Schiuma1, Martin Thalhauser1, Ludovic Bouré1, Stephan Zeiter1.
Abstract
Critical sized bone defect (CSBD) animal models are used to evaluate and confirm efficacy and potency of new treatment modalities based on bone tissue engineering before the latter can be applied in clinical practice. In this study, a bilateral CSBD model in the iliac wings of sheep is described in detail. To demonstrate that this is a large animal CSBD model in sheep, bone healing within the defect left empty (negative control) or filled with autologous corticocancellous bone graft (clinical gold standard, positive control) was assessed using micro-CT, histology, histomorphometric, and fluorochrome analysis. After three months, new bone into the defect site was formed across the whole defect in the positive controls but limited to the edge of the defects in the negative controls. Bone volume in the positive controls was statistically higher than in the negative controls, with the latter having less than 10% new bone growth. There were no intraoperative or postoperative complications. The model described here represents a reliable and reproducible bilateral CSBD in sheep with low morbidity that can be used for in vivo evaluation of new treatment modalities based on bone tissue engineering.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24696845 PMCID: PMC3947786 DOI: 10.1155/2014/250958
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Figure 1(a) Photograph of the custom-made jig and the 17 mm coring device used to create the defect. (b) Orientation of the jig with two 2.0 mm K-wires located dorsally (top white arrows) and one 2.5 mm K-wire located centrally through the coring device which is subsequently placed through the jig (bottom white arrow).
Figure 2Photograph of a bone specimen from a Swiss alpine white sheep showing the anatomical orientation (a and b) and the cranial ventral locating screws along the iliac crest and central 17 mm defect (a).
Figure 3(a) Resulting empty defect. (b) Morselized corticocancellous bone graft stacked within the defect. Note the closure at the craniomedial aspect (black arrow).
Figure 4Photomicrograph of a positive control defect (a) and negative control defect (b) within the ROI (white circle). New bone growth into the positive control defect was widespread, while new bone growth into the empty defect occurred restricted to the edge of the defect. Dense connective tissue was the major tissue in the empty defect (∗). The sections were stained with Giemsa-eosin.
Figure 5Representative micro-CT 3D reconstructions of positive control defects (treated with autologous bone) (a) and negative control defects (left empty) (b).
Comparison of bone volume and bone density between the two groups as determined by micro-CT analysis.
| Group | Mean bone volume (mm3) (Mean ± SD) | Mean bone density (mg HA/cm3) (Mean ± SD) |
|---|---|---|
| Autograft—positive control | 520.1 ± 123.8* | 587.3 ± 17.3 |
| Empty—negative control | 224.3 ± 84.1* | 576.5 ± 18.0 |
*Indicates significant differences.
Figure 6Fluorochrome images of positive control defect (a) showing the widespread new bone growing into the defect and negative control defect (b) showing that the fluorochromes are confined to the edges with minimal bone growth after 3 weeks. Fluorochromes were given at three weeks (calcein green), at six weeks (xylenol orange), and at nine weeks after surgery (oxytetracycline).